1503PBenefit of the use of tyrosine kinase inhibitors...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1503PBenefit of the use of tyrosine kinase inhibitors (TKIs) in patients (pts) with METAstatic Soft Tissue SARComa (STS) in a Real-Life Setting: an ancillary analysis of the METASARC Study

Cousin, S., Savina, M., Le Cesne, A., Blay, J-Y., Ray-Coquard, I., Mir, O., Toulmonde, M., Terrier, P., Ranchere-Vince, D., Meeus, P., Stoeckle, E., Honore, C., Sargos, P., Sunyach, M.P., Le Pechoux,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx387.029
Date:
September, 2017
File:
PDF, 45 KB
english, 2017
Conversion to is in progress
Conversion to is failed